Contract sales organisations: Making the transition from tactical resource to strategic partnering

Journal of Medical Marketing

Volumn 8, Issue 1, 2008, Pages 39-47

  Rogers, Beth ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37449021604     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1057/palgrave.jmm.5050119     Document Type: Article

References (34)

1. Leask, G. (2004). Strategic groups and the resource based view: Natural complements enhancing our understanding of the competitive process, Research Paper No 0405, Aston Business School Research Institute, Birmingham.
2. Foss, N.J. (1999). Research in the strategic theory of the firm: "isolationism" and "integrationism". J. Manage. Stud. 36 6), 725-755.
3. Kakabadse, A. & Kakabadse, N. (2002). Smart Sourcing: International Best Practice, Palgrave, Basingstoke.
4. Zhu, Z., Hsu, K. & Lillie, J. (2001). Outsourcing - a strategic move: the process and the ingredients for success. Manage. Decis. 39 5), 373-378.
5. Anon (2003). IOMA survey ranks strategic expectations for outsourcing. Financial Executive's News, 1st June, 2003 3(6), 4, http://www.ioma.com.
6. Smith, J. A., Morris, J. & Ezzamel, M. (2005). Organisabonal change, outsourcing and the impact on management accounting. Brit. Account. Rev. 37, 415-441.
7. Marshall, J. & Heffes, E. M. (2005). Outsourcing study: Many firms question benefits. Finan. Exec. 21(5), 10.
8. Morgan, R. E. (2003). Outsourcing: Towards the shamrock organization. J. Gen. Manage. 29(2), 35-52.
9. Tjosvold, D. (1984). Co-operation theory and organizations. Hum. Relat. 37(9), 743-767.
10. Lin, B. & Darling, J. (1999). An analysis of the formulation of strategic alliances: A focus on the pharmaceutical industry. Ind. Manage. Data Syst. 99(3), 121-127.
11. CanBiotech (2005) Biopharmaceutical Outsourcing Outlook, www.canbiotech.com, http://www.biomedical-outsourcing.com/CommonData/ Resources/AnnualIssue.pdf, downloaded 22nd March, 2007.
12. Borchardt, J. K. (2000). Playing the economics game with outsourcing. Mod. Drug Discover. 3(2), 28-34.
13. Anon (2006). The future of outsourcing, Datamonitor. Marketwatch: Technology 5(5), 30-31.
14. www.healthservicetalk.com, Global drug outsourcing hits $30bn by 2011, 26th October, 2006, http://www.healthservicetalk.com/news/kal/ kal116.html, downloaded 22nd March, 2007.
15. www.get.hobsons.co.uk/profile/1451/innovex, accessed 22nd March, 2007.
16. Bousfield, P. (2003). The business case for call centre outsourcing. Interact. Market. 4(2), 111-116.
17. Anderson, E. & Trinkle, B. (2005). Outsourcing the Sales Function: The Real Cost of Field Sales, Thomson/South-western, Mason, OH.
18. Ross Jr., W. T., Dalsace, F. & Anderson, E. (2005). Should you set up your own sales force or should you outsource it? Pitfalls in the standard analysis. Bus. Horizons 48, 23-36.
19. Gardner, N. (2004). Pharmaceutical marketing tactics hold little sway with prescribing physicians, http://uwnews.org, 7th December, 2004, http://uwnews.org/aticle.asp?articleid-6830, downloaded 22nd March, 2007.
20. Sederman, R. (2004). Deconstructmg the sales force stalemate. Success. Sales Manage. 24, 6-12.
21. Accenture (2001). How much are pharmaceutical marketing and sales capabilities really worth? www.accenture.com, http://www.accenture.com/ Global/Research_and_Insights/By_Industry/Health_and_Life_Sciences/ Pharmaceuticals_and_Medical_Products/HowWorth.htm, downloaded 3rd March, 2007.
22. Mizik, N. & Jacobson, R. (2004). Are physicians "easy marks"? Quantifying the effects of detailing and sampling on new prescriptions. Manage. Sci. 50(12), 1704-1715.
23. Davenport, B., Fisher, C. & Rosner, E. (2007). Sales slip. Pharmaceut. Executive 27(1), 68-74.
24. May, J. (2005), Breaking the mould. Pharmaceutical Field Yearbook, 2005, www.takeda.co.uk/press_releases/pfield-dec2005-breaking.pdf, downloaded 22nd March, 2007.
25. Anon. (2006). Fastest growing companies: Takeda. InPharm Guide to Pharma Careers. Published in Pharmafocus 8(11), November 2006.
26. Dimopoulou, E. & Fill, C. (2000). Corporate identity cues: The significance of the sales force. Int. J. Med. Market. 1(1), 9-19.
27. Williamson, J. E. (2002). The chameleons of pharma. Pharmaceutical Representative, 1st November, 2002. http://www.pharmrep.com/pharmrep/ ardcle/articleDetail.jsp?id=125328, downloaded 23rd March, 2007.
28. von Clausewitz, C. (1832). Von Kriege, Dümmlers Verlag, Berlin.
29. Phelan, S. E. & Lewin, P. (2000). Arriving a strategic theory of the firm. Int. J. Manage. Rev. 2 (4), 305-323.
30. Mohr, J.J. & Spekman, R. E. (1996). Perfecting partnerships. Market. Manage. 4(4), 34-43.
31. O'Connor Vos, L. (2003). Bring in the reinforcements. Pharmaceut. Executive 23(5), 82-83.
32. Collado, R. (2006). Hired hands. Med. Market. Media 41(11), 44-45.
33. Anon (2005). Sales partnership makes a healthy profit for Mölnlycke. Ind. Comm. Train. 37(6-7), 369.
34. Budd, S. K. (2004). In or out: Outsourcing in today's biopharmaceutical industry, www.pdi-inc.com/articles/txt_inorout.htm, downloaded 22nd March, 2007.